Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME), which exhibit signaling including transforming growth factor-beta (TGF-β), are critical for promoting therapeutic resistance (52). The gene discussed is TGFB1; the disease is neoplasm.